Suzhou MedicalSystem Technology Co., Ltd.

SSE:603990.SS

15.83 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42014 Q22014 Q1
Revenue 63.34104.994104.02143.672111.382268.088196.68782.59270.77599.70762.89185.94356.966135.73366.681104.33847.093138.43880.56972.68616.386155.07957.71679.37140.95123.80859.39164.69836.379102.0861.78271.74133.07795.06754.18962.21229.17589.32835.81435.814
Cost of Revenue 21.47582.97682.043161.86973.828314.603134.89323.50119.29630.25118.83727.12313.8435.40118.3841.26311.81541.19921.46117.2395.46946.87717.31717.83311.00432.48820.48710.6658.95131.39513.28719.1646.76925.60514.80920.34214.2561.09410.07610.076
Gross Profit 41.86522.01721.978-18.19737.554-46.51561.79459.09151.47969.45744.05458.8243.126100.33348.30163.07535.27897.23959.10855.44810.917108.20240.39961.53829.94691.3238.90454.03327.42970.68548.49552.57826.30869.46239.3841.8714.92528.23425.73725.737
Gross Profit Ratio 0.6610.210.211-0.1270.337-0.1740.3140.7150.7270.6970.70.6840.7570.7390.7240.6050.7490.7020.7340.7630.6660.6980.70.7750.7310.7380.6550.8350.7540.6920.7850.7330.7950.7310.7270.6730.5120.3160.7190.719
Reseach & Development Expenses 6.8518.13312.45615.14115.44917.3610.98911.34810.3429.32914.01813.88110.18321.86711.8288.3255.9849.50611.91310.87510.73913.57615.85814.39113.86216.59212.69314.2113.75214.76713.10719.956035.228011.457020.0562.7242.724
General & Administrative Expenses 17.618-75.07194.112-51.10363.679-96.098120.482-8.55729.972-25.71937.357-5.55812.947-26.8239.078-0.93113.122-20.91812.51-6.61911.979-23.97513.101-5.9512.338-24.94812.08-17.42924.962-51.10124.418-14.02118.63926.36117.773-7.10712.39449.8089.4989.498
Selling & Marketing Expenses 11.391-52.46844.04621.01515.6723.29118.19321.35417.34416.64518.50714.57711.8224.22220.67818.39716.08431.96617.36417.4019.89222.4716.07918.83616.30919.15414.05117.19814.19618.74414.26814.23615.30719.87314.25516.09611.35155.10614.33514.335
SG&A 29.009-191.557138.15833.9379.349-72.807138.67512.79747.316-9.07555.8649.01924.767-2.59859.75617.46629.20511.04829.87410.78321.871-1.50529.18112.88628.648-5.79526.13-0.23139.157-32.35638.6870.21633.94646.23432.0288.98923.746109.58523.83323.833
Other Expenses -20.323253.614-43.6-4.31-0.1551.971-0.01-0.034-0.31139.628-23.98916.068-3.247-0.044-0.00618.115-0.307-0.097-0.034-0.332-0.419-7.408-0.3671.111-0.5960.223-0.231-0.5070.4782.6204.1595.9547.9335.5261.8219.8393.83700
Operating Expenses 15.538142.766110.00553.38110.45891.44374.51594.47357.34739.88245.89338.96731.70257.36848.84943.90628.77843.97138.08937.02126.26448.48430.47242.58334.52134.07232.90237.70932.13343.48431.98835.63635.10848.36633.05130.03723.9863.83718.80418.804
Operating Income 26.326-122.392-72.143-71.57812.855-184.823-29.602-43.068-4.45518.312-0.47520.23613.27531.294-1.8611.43610.51638.9213.60612.452-16.25942.1534.52911.438-4.19248.433.01314.486-5.45521.1615.33515.282-8.99217.5125.60412.416-11.42132.0711.3061.306
Operating Income Ratio 0.416-1.166-0.694-0.4980.115-0.689-0.151-0.521-0.0630.184-0.0080.2350.2330.231-0.0280.110.2230.2810.1690.171-0.9920.2720.0780.144-0.1020.3910.0510.224-0.150.2070.2480.213-0.2720.1840.1030.2-0.3910.3590.0360.036
Total Other Income Expenses Net -0.42628.19-16.102-12.409-0.1551.971-0.01-0.034-1.969-0.4980.0010-0.005-0.044-0.0060.2430-0.097-0.034-0.0150-0.00500.553-00.223-0.231-0.5070.4782.6204.1595.9547.9335.5261.8219.8397.0626.4766.476
Income Before Tax 25.901-94.375-88.245-83.81512.7-182.853-29.612-43.102-6.42417.813-1.54114.01413.2731.25-1.86611.43610.51638.82313.57212.437-16.25942.1484.52911.438-4.19248.6532.78113.979-4.97723.7815.33519.44-3.03825.44611.1314.237-1.58239.1336.9996.999
Income Before Tax Ratio 0.409-0.899-0.848-0.5830.114-0.682-0.151-0.522-0.0910.179-0.0250.1630.2330.23-0.0280.110.2230.280.1680.171-0.9920.2720.0780.144-0.1020.3930.0470.216-0.1370.2330.2480.271-0.0920.2680.2050.229-0.0540.4380.1950.195
Income Tax Expense 1.02117.1462.6122.1062.002-6.1492.6183.0413.7440.741.4943.0122.8213.2730.4121.562.5873.0811.9471.3610.2195.2380.0741.3570.1384.9212.757-2.234-0.0691.928-0.2442.5950.1271.872-0.1482.0940.206117.0950.8480.848
Net Income 23.596-112.254-90.886-86.2279.891-177.357-34.276-47.013-10.16816.155-3.03510.8029.35527.717-2.1969.7176.71533.6759.4768.718-16.42736.0234.70410.259-4.144.0540.1216.213-4.90721.85115.57916.845-3.16523.57411.27712.143-1.78834.1156.1516.151
Net Income Ratio 0.373-1.069-0.874-0.60.089-0.662-0.174-0.569-0.1440.162-0.0480.1260.1640.204-0.0330.0930.1430.2430.1180.12-1.0030.2320.0820.129-0.10.3560.0020.251-0.1350.2140.2520.235-0.0960.2480.2080.195-0.0610.3820.1720.172
EPS 0.08-0.37-0.3-0.280.03-0.58-0.11-0.16-0.0340.059-0.020.0690.0460.1-0.0130.0580.0240.180.030.061-0.0650.240.0180.069-0.0180.30.0010.11-0.020.150.0620.12-0.0130.220.0620.11-0.010.310.0340.034
EPS Diluted 0.08-0.37-0.3-0.280.03-0.58-0.11-0.16-0.0340.059-0.020.0690.0460.1-0.0130.0580.0240.180.030.061-0.0650.240.0180.069-0.0180.30.0010.11-0.020.150.0620.12-0.0130.220.0620.11-0.010.310.0340.034
EBITDA 30.134-23.243-69.404-40.97131.173-150.543-21.076-30.4040.16330.1570.29819.36118.4537.923.5617.56116.69540.42115.94618.042-10.81243.7545.7916.868-2.88856.5327.05116.096-3.67227.31618.52126.632-7.372-94.1636.75822.51-7.152-65.29800
EBITDA Ratio 0.476-0.221-0.667-0.2850.28-0.562-0.107-0.3680.0020.3020.0050.2250.3240.2790.0530.1680.3550.2920.1980.248-0.660.2820.10.213-0.0710.4570.1190.249-0.1010.2680.30.371-0.223-0.990.1250.362-0.245-0.73100